Literature DB >> 23473465

Synthetic cannabinoid use associated with acute kidney injury.

Stephen L Thornton, Clayton Wood, Matthew W Friesen, Roy R Gerona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23473465     DOI： 10.3109/15563650.2013.770870

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN： 1556-3650            Impact factor:   4.467


× No keyword cloud information.
  19 in total

1.  Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.

Authors:  Brian F Thomas; Timothy W Lefever; Ricardo A Cortes; Megan Grabenauer; Alexander L Kovach; Anderson O Cox; Purvi R Patel; Gerald T Pollard; Julie A Marusich; Richard C Kevin; Thomas F Gamage; Jenny L Wiley
Journal:  J Pharmacol Exp Ther       Date:  2017-01-13       Impact factor: 4.030

Review 2.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

3.  First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.

Authors:  Ariane Wohlfarth; Shaokun Pang; Mingshe Zhu; Adarsh S Gandhi; Karl B Scheidweiler; Hua-fen Liu; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-09-06       Impact factor: 8.327

4.  In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors.

Authors:  Shivani Sachdev; Kiran Vemuri; Samuel D Banister; Mitchell Longworth; Michael Kassiou; Marina Santiago; Alexandros Makriyannis; Mark Connor
Journal:  Br J Pharmacol       Date:  2019-12-10       Impact factor: 8.739

5.  Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model.

Authors:  T W Grim; A J Morales; B F Thomas; J L Wiley; G W Endres; S S Negus; A H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2017-04-25       Impact factor: 4.030

6.  Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.

Authors:  Kevin G Shanks; William Clark; George Behonick
Journal:  J Anal Toxicol       Date:  2016-01-10       Impact factor: 3.367

7.  Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22.

Authors:  George Behonick; Kevin G Shanks; Dennis J Firchau; Gagan Mathur; Charles F Lynch; Marcus Nashelsky; David J Jaskierny; Chady Meroueh
Journal:  J Anal Toxicol       Date:  2014-05-29       Impact factor: 3.367

8.  First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry.

Authors:  Adarsh S Gandhi; Mingshe Zhu; Shaokun Pang; Ariane Wohlfarth; Karl B Scheidweiler; Hua-Fen Liu; Marilyn A Huestis
Journal:  AAPS J       Date:  2013-08-03       Impact factor: 4.009

Review 9.  A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.

Authors:  Vineet S Gudsoorkar; Jose A Perez
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jul-Sep

10.  High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.

Authors:  Adarsh S Gandhi; Ariane Wohlfarth; Mingshe Zhu; Shaokun Pang; Marisol Castaneto; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-05-14       Impact factor: 3.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.